20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Weight Loss in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barden, AE; Beilin, LJ; Croft, KD; Phillips, M; Puddey, IB; van Bockxmeer, F; Ward, NC | 1 |
| Barden, AE; Beilin, LJ; Croft, KD; Falck, JR; Mori, TA; Puddey, IB; Tsai, IJ | 1 |
2 trial(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Weight Loss
| Article | Year |
|---|---|
The effect of a single nucleotide polymorphism of the CYP4F2 gene on blood pressure and 20-hydroxyeicosatetraenoic acid excretion after weight loss.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Female; Genetic Association Studies; Heart Rate; Humans; Hydroxyeicosatetraenoic Acids; Lipids; Male; Middle Aged; Overweight; Polymorphism, Single Nucleotide; Vascular Stiffness; Weight Loss; Young Adult | 2014 |
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
Topics: Adult; Aged; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; F2-Isoprostanes; Female; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Metabolic Syndrome; Middle Aged; Obesity; Oxidative Stress; Risk Factors; Weight Loss | 2009 |